Methods of modifying eukaryotic cells

Details for Australian Patent Application No. 2002220048 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Murphy, Andrew J; Yancopoulos, George D; Valenzuela, David M; Economides, Aris N.; Frendewey, David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002220048

PCT Pub. Number WO02/36789

Priority 60244665 31.10.00 US; 09732234 07.12.00 US

Filing date 31 October 2001

Wipo publication date 15 May 2002

Acceptance publication date 21 September 2006

International Classifications

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

C12N 15/90 (2006.01) Mutation or genetic engineering

Event Publications

21 September 2006 Application Accepted

  Published as AU-B-2002220048

18 January 2007 Standard Patent Sealed

22 March 2007 Section 223 Application Received

  Regeneron Pharmaceuticals, Inc. An application to extend the time from 13 Nov 2005 to 13 Feb 2007 in which to file search results has been filed . Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000

17 May 2007 Section 223 Application Allowed

  Regeneron Pharmaceuticals, Inc. The time in which to file search results has been extended to 13 Feb 2007. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002220049

2002220047